Showing results (2331-2340 of 4,783) with videos related to
Sort By:
Pageof 479
Drug Discovery Today|August 12, 2026
Deubiquitinase-targeting chimeras (DUBTACs): a game-changing approach for targeted protein stabilization in drug discoveryGebremedhin Solomon Hailu, Emanuele Fabbrizi, Andrea Mancini, et al.Drug Discovery Today|August 18, 2026
Patient experience data as a methodological and strategic innovation in clinical trial designAlice Vanneste, Axelle Jankelevitch, Linda Lukeba, et al.Drug Discovery Today|August 14, 2026
Model Gateway: Management platform for model-driven drug discoveryYan-Shiun Wu, Sai Mahit Vaddadi, Zachary A Rollins, et al.Drug Discovery Today|September 28, 2026
Paradigm shift in the management of drug development projects: artificial-intelligence-enabled parallel scenario execution for managing uncertaintyShinichi Tsuchiwata, Misaki Ishii, Takahiko Aoyama, et al.Drug Discovery Today|September 30, 2026
Agonist-informed antagonist discovery: Discovery approaches, medicinal chemistry insights, and design boundariesBojia Liu, Caiyiren Wen, Zeyu Han, et al.Drug Discovery Today|October 15, 2026
Advancing a drug-development program is not the same as de-risking itMileidys Perez-AleaDrug Discovery Today|September 23, 2026
Drug discovery strategies targeting B7-H3 (CD276) in lung and gastric cancers: From biological validation to next-generation small molecules, biologics and cell-based immunotherapiesSoorya Suresh, Surabhi Maurya, Kajal Singh, et al.Drug Discovery Today|October 5, 2026
Regulatory sandboxes for drug development: from uncertainty to structured evidence generationPedro Franco, Maximilian Otte, Gökhan Ertaylan, et al.Drug Discovery Today|October 3, 2026
Revisiting the potential of elongation factors as drug targets for pathogenic mycobacteriaMushtaq Ahmad Wani, Shivani Gurjar, Ajay Kumar, et al.Drug Discovery Today|October 6, 2026
ADMET all-inclusive: Accountability for the full end-to-end model life cycle is key to successLara Kuhnke, Andreas H GöllerPageof 479